PPT-Access to Medicines in Light of Patent Law Regime in India
Author : tawny-fly | Published Date : 2016-06-14
A LEGACY OF LEGISLATION OR LEASE OF THE JUDICIARY State of Public Health of India HepatitisB most common food or waterborne disease in India National Center for
Presentation Embed Code
Download Presentation
Download Presentation The PPT/PDF document "Access to Medicines in Light of Patent L..." is the property of its rightful owner. Permission is granted to download and print the materials on this website for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.
Access to Medicines in Light of Patent Law Regime in India: Transcript
A LEGACY OF LEGISLATION OR LEASE OF THE JUDICIARY State of Public Health of India HepatitisB most common food or waterborne disease in India National Center for Biotechnology Information . ‘ . Balm of America’: Nationalism, Advertising, and . Proprietary Medicines in Nineteenth-Century America. . Abstract:. Proprietary medicines flourished in the nineteenth century. As Americans struggled to make sense of the new nation, savvy businesspeople and owners of patent formulas drew on new forms and methods of advertising to increase distribution and profits of such items as cure-alls, elixirs, fever powders, salves and medical devices. With little government regulation or resistance from the very-young professional medical community until the late 1800s, proprietary medicines found a niche in lay usage across the United States due to advertising campaigns that stressed uniqueness, scarcity, efficacy, and a distinctly American quality of the product. This poster visually demonstrates how advertisers linked health to nationalism to legitimate and sell products that, within a century, came to be termed "quackery" and "snake-oil".. Professor Amir Attaran. Canada Research Chair. Institute of Population Health and Faculty of Law. How India’s drug laws work. India’s “FDA” is the Central Drugs Standard Control Organization (CDSCO). India’s “FDA Commissioner” is the Drug Controller General of India (DCGI).. Prepared for Topics in Quantitative Finance | . Abhishek. . Rane. - . Andrew . Ang. and Allan Timmermann. Paper. . Structure. . . Introduction to Economic Regimes. Model Specification. Capturing Statistical Properties. Prof. Ravi Sinha, IIT Bombay. Technical Session 2: . Strengthening Disaster Risk Governance to Manage Disaster Risk . Disaster Risk in India. Around 85% of the country is prone to one or more disasters. Stops AIDS National Gathering . 1st November 2014. Aliénor Devali. ère. Health. Action International (HAI) Europe. This document arises from HAI Europe’s Operating Grant 2014, which has received funding from the . Gilles Forte. Policy. , Access and Use Team. Department for Essential . Medicines and Health Products. World Health Assembly Resolution 67.22 . Access . to essential medicines. Recognize . the importance of effective national medicines policies, and their . sustainably and equitably financed. Summary Discussion…1. What information needed to estimate cost program of medicines benefits. MBM . Ned to estimate the total economic cost of setting up a MBM program. . The Hepatitis C Treatment Revolution . Expanding Access to HIV Co-Infected and Beyond. UNITAID, MSF, WHO . IAC, Melbourne 21 July, 2014. Drugs of Interest - Hepatitis C. . Sofosbuvir. Will likely be backbone of HCV all-oral pan-genotypic regimens. Draft concept for a new World Bank-led multi-stakeholder initiative . August 2014, Andreas . Seiter. What is AIM 2030?. An initiative to maximize access to innovative medicines for priority diseases in low- and middle income countries (LMICs). Case Management. George Jagoe . EVP, Access & Product Management, MMV. . . The access team at MMV is heavily focused on the needs of control today. 4. Achieving patient impact means addressing many hurdles to access. Once . the protection of the product . expires for . example, patents or regulatory protection such as data . exclusivity, . the company no longer has exclusive rights to sell the medicine. . Other . how . the pandemic has influenced the disease burden. Bengt . Jönsson. Professor emeritus, Stockholm School of Economics. Wednesday, 1 July 2020 – 16.30-19.00 CET (online event. ). Launch of the European Parliament . . Make Medicines Affordable. ITPC . Tracy Swan ITPC. Make Medicines Affordable (MMA) consortium believes it is every person’s right to access the treatment they need, and that intellectual barriers (IP) preventing this must be removed.. Basic enquiry answering. September . 2016. Session aims. Increase awareness of the Medicines Information (MI) services. UK. Wales. Increase awareness of the questions to ask an enquirer. Have practical experience using some resources which will be...
Download Document
Here is the link to download the presentation.
"Access to Medicines in Light of Patent Law Regime in India"The content belongs to its owner. You may download and print it for personal use, without modification, and keep all copyright notices. By downloading, you agree to these terms.
Related Documents